Hunton Andrews Kurth LLP represented Goose Capital in its investment in Immix Biopharma, Inc. (NASDAQ: IMMX), a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and other serious diseases.

Additional information about the transaction is available here.

Goose Capital is an investment firm comprised of former Fortune 500 executives, industry leaders, and serial entrepreneurs. Goose Capital invests in breakthrough technologies, early-stage startups, and innovative founders.

Hunton attorneys Lee Davis, Jeff Dodd, and Candace Cravey represented Goose Capital.